124 related articles for article (PubMed ID: 7080958)
1. Protein binding and clearance of oxaprozin, a highly bound anti-inflammatory agent.
Homon CA; Fluck ER; Janssen FW; Ruelius HW
Agents Actions; 1982 Apr; 12(1-2):211-5. PubMed ID: 7080958
[TBL] [Abstract][Full Text] [Related]
2. Inverse nonlinear pharmacokinetics of total and protein unbound drug (oxaprozin): clinical and pharmacokinetic implications.
Karim A
J Clin Pharmacol; 1996 Nov; 36(11):985-97. PubMed ID: 8973987
[TBL] [Abstract][Full Text] [Related]
3. Oxaprozin dose proportionality.
Chiang ST; Lasseter KC; Fluck ER; Janssen FW; Leelavathi D; Hubsher JA
J Clin Pharmacol; 1984; 24(11-12):515-22. PubMed ID: 6511991
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and kinetics of oxaprozin in normal subjects.
Janssen FW; Jusko WJ; Chiang ST; Kirkman SK; Southgate PJ; Coleman AJ; Ruelius HW
Clin Pharmacol Ther; 1980 Mar; 27(3):352-62. PubMed ID: 7357792
[TBL] [Abstract][Full Text] [Related]
5. Oxaprozin disposition in renal disease.
Chiang ST; Morrison G; Knowles JA; Ruelius HW; Walker BR
Clin Pharmacol Ther; 1982 Apr; 31(4):509-15. PubMed ID: 7060332
[TBL] [Abstract][Full Text] [Related]
6. Macro- and micromethods for high-performance liquid chromatographic analysis of oxaprozin in plasma.
McHugh SL; Kirkman SK; Knowles JA
J Pharm Sci; 1980 Jul; 69(7):794-6. PubMed ID: 7391941
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic renal failure on oxaprozin multiple-dose pharmacokinetics.
Audet PR; Knowles JA; Troy SM; Walker BR; Morrison G
Clin Pharmacol Ther; 1988 Sep; 44(3):303-9. PubMed ID: 3416552
[TBL] [Abstract][Full Text] [Related]
8. Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics.
Karim A; Noveck R; McMahon FG; Smith M; Crosby S; Adams M; Wilton J
J Clin Pharmacol; 1997 Apr; 37(4):267-78. PubMed ID: 9115051
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of oxaprozin.
Davies NM
Clin Pharmacokinet; 1998 Dec; 35(6):425-36. PubMed ID: 9884815
[TBL] [Abstract][Full Text] [Related]
10. Oxaprozin pharmacokinetics in patients with congestive heart failure.
Ochs HR; Greenblatt DJ; Knüchel M
Arzneimittelforschung; 1986 Dec; 36(12):1837-40. PubMed ID: 3566846
[TBL] [Abstract][Full Text] [Related]
11. A multicentre double-blind comparison of oxaprozin aspirin therapy on rheumatoid arthritis.
Hubsher JA; Ballard IM; Walker BR; Gold JA
J Int Med Res; 1979; 7(1):69-76. PubMed ID: 369925
[TBL] [Abstract][Full Text] [Related]
12. Effects of oxaprozin alone or in combination with aspirin on hemostasis and plasma protein binding.
Kahn SB; Hubsher JA
J Clin Pharmacol; 1983 Apr; 23(4):139-46. PubMed ID: 6863578
[TBL] [Abstract][Full Text] [Related]
13. Disposition of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin) in beagle dogs and rhesus monkeys.
Janssen FW; Kirkman SK; Knowles JA; Ruelius HW
Drug Metab Dispos; 1978; 6(4):465-75. PubMed ID: 28928
[TBL] [Abstract][Full Text] [Related]
14. Rapid high-performance liquid chromatographic analysis of oxaprozin, a non-steroidal anti-inflammatory agent.
Matlis R; Greenblatt DJ
J Chromatogr; 1984 Oct; 310(2):445-9. PubMed ID: 6511863
[No Abstract] [Full Text] [Related]
15. Effects of food on oxaprozin bioavailability.
Chiang ST; Knowles JA; Hubsher JA; Ruelius HW; Walker BR
J Clin Pharmacol; 1984; 24(8-9):381-5. PubMed ID: 6480879
[TBL] [Abstract][Full Text] [Related]
16. Oxaprozin pharmacokinetics in the elderly.
Greenblatt DJ; Matlis R; Scavone JM; Blyden GT; Harmatz JS; Shader RI
Br J Clin Pharmacol; 1985 Mar; 19(3):373-8. PubMed ID: 3986088
[TBL] [Abstract][Full Text] [Related]
17. Interaction of oxaprozin with acetaminophen, cimetidine, and ranitidine.
Scavone JM; Greenblatt DJ; Matlis R; Harmatz JS
Eur J Clin Pharmacol; 1986; 31(3):371-4. PubMed ID: 3792438
[TBL] [Abstract][Full Text] [Related]
18. Gastroscopic evaluation of the effect of aspirin and oxaprozin on the gastric mucosa.
Lanza FL; Hubsher JA; Walker BR
J Clin Pharmacol; 1981 Apr; 21(4):157-61. PubMed ID: 7240437
[TBL] [Abstract][Full Text] [Related]
19. The transsynovial distribution of oxaprozin.
Kurowski M; Thabe H
Agents Actions; 1989 Jun; 27(3-4):458-60. PubMed ID: 2801338
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal blood loss of oxaprozin and aspirin with placebo control.
Lussier A; LeBel E; Tétreault L
J Clin Pharmacol; 1982 Apr; 22(4):173-8. PubMed ID: 6980231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
